Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Luca Bollo
Live Attenuated Measles-Mumps-Rubella and Varicella Vaccinations and Multiple Sclerosis Activity
Live Attenuated Measles-Mumps-Rubella and Varicella Vaccinations and Multiple Sclerosis Activity Supplement 1. eFigure 1. Love Plot Showing Covariate Balance Before and After Propensity Score Weighting eFigure 2. Unweighted Estimates of Relapse Risk Supplement 2. (opens in new tab) Vaccination was decided by measles-mumps-rubella (MMR) and/or varicella serostatus. Time 0 for the vaccination group was defined as the date of the first dose of live attenuated varicella and/or MMR vaccine.
Optic nerve imaging with OCT predicts disease progression and monitors brain and spinal atrophy in primary progressive multiple sclerosis
Information, rights and permissions Information Published In Article first published online: January 30, 2026 Keywords Optical coherence tomography (OCT) PPMS pRNFL Rights and permissions © The Author(s), 2026. Request permissions for this article.
A single-dose strategy for immunization with live attenuated vaccines is an effective option before treatment initiation in multiple sclerosis patients - René Carvajal, Carmen Tur, Xavier Martínez-Gómez, Luca Bollo, Juliana Esperalba, Marta Rodriguez, Agu
Introduction People with multiple sclerosis (pwMS) exposed to highly effective disease-modifying therapies (DMTs) are at higher risk of infections and complications, some of which are preventable through vaccination, such as varicella and/or measles.1,2 Live attenuated vaccines, such as varicella (VAR) and measles-mumps-rubella (MMR), are contraindicated in patients receiving immunosuppressive therapies.
A single-dose strategy for immunization with live attenuated vaccines is an effective option before treatment initiation in multiple sclerosis patients - René Carvajal, Carmen Tur, Xavier Martínez-Gómez, Luca Bollo, Juliana Esperalba, Marta Rodriguez, Agu
Introduction People with multiple sclerosis (pwMS) exposed to highly effective disease-modifying therapies (DMTs) are at higher risk of infections and complications, some of which are preventable through vaccination, such as varicella and/or measles.1,2 Live attenuated vaccines, such as varicella (VAR) and measles-mumps-rubella (MMR), are contraindicated in patients receiving immunosuppressive therapies.
Dengue fever in a multiple sclerosis patient taking Ocrelizumab
Dengue fever (DF) is an endemic infectious disease in tropical and subtropical regions. Ocrelizumab is a humanized monoclonal antibody that targets the CD20 antigen on B cells, which is approved for the treatment of both relapsing-remitting multiple sclerosis (RRMS) and primary-progressive multiple sclerosis (PPMS).
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Luca
Contact Luca, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack